Drugs using in surgery of diseased gums for covering exposed tooth root
- Conditions
- Health Condition 1: K053- Chronic periodontitis
- Registration Number
- CTRI/2023/06/054274
- Lead Sponsor
- Institute Of Dental Sciences, Bareilly
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients having Millerâ??s Class I and II gingival recession depth of greater than equals to 2mm in upper and lower teeth.
2. Presence of greater than equals to 1 mm high keratinised tissue apical to root exposure.
3. Presence of identifiable cementoenamel junction.
4. Patients with good general health.
1. Systemically compromised patients e.g., Diabetes Mellitus, Cardiovascular disorders etc.
2. Patients who will be on medications that could interfere with wound healing and bone metabolism.
3. Pregnant and lactating females.
4. Current and past smokers.
5. Patients who will be treated for any periodontal ailments in the past 6 months.
6. Teeth with occlusal disharmony.
7. Patients with parafunctional habit.
8. Frenum pull at attached gingiva
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluating clinical efficiency of hyaluronic acid with amniotic membrane for recession coverage using coronally advanced flap. <br/ ><br>Comparing the efficacy & treatment outcomes of hyaluronic acid with amniotic membrane & amniotic membrane alone for Class I & II (Miller) gingival recession coverage procedure using coronally advanced flap.Timepoint: 0 3 & 6 months
- Secondary Outcome Measures
Name Time Method Evaluating clinical efficiency of amniotic membrane alone for recession coverage using coronally advanced flap.Timepoint: 0 3 6 months